Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Evaluation of innate immune signaling pathways in transformed cells.

Heiber JF, Barber GN.

Methods Mol Biol. 2012;797:217-38. doi: 10.1007/978-1-61779-340-0_15. Review.

PMID:
21948479
2.

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.

Naik S, Russell SJ.

Expert Opin Biol Ther. 2009 Sep;9(9):1163-76. doi: 10.1517/14712590903170653. Review.

PMID:
19637971
3.

Oncolytic viruses for induction of anti-tumor immunity.

Tong AW, Senzer N, Cerullo V, Templeton NS, Hemminki A, Nemunaitis J.

Curr Pharm Biotechnol. 2012 Jul;13(9):1750-60. Review.

PMID:
21740355
4.

Combining oncolytic virotherapy and tumour vaccination.

Bridle BW, Hanson S, Lichty BD.

Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):143-8. doi: 10.1016/j.cytogfr.2010.02.009. Epub 2010 Mar 11. Review.

PMID:
20226716
5.

Triggering the innate antiviral response through IRF-3 activation.

Hiscott J.

J Biol Chem. 2007 May 25;282(21):15325-9. Epub 2007 Mar 29. Review.

6.

VSV-tumor selective replication and protein translation.

Barber GN.

Oncogene. 2005 Nov 21;24(52):7710-9. Review.

PMID:
16299531
7.

Cytoplasmic DNA innate immune pathways.

Barber GN.

Immunol Rev. 2011 Sep;243(1):99-108. doi: 10.1111/j.1600-065X.2011.01051.x. Review.

PMID:
21884170
8.

Toll-like receptors and Type I interferons.

Uematsu S, Akira S.

J Biol Chem. 2007 May 25;282(21):15319-23. Epub 2007 Mar 29. Review.

9.

Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.

Seya T, Matsumoto M, Ebihara T, Oshiumi H.

Immunol Rev. 2009 Jan;227(1):44-53. doi: 10.1111/j.1600-065X.2008.00723.x. Review.

PMID:
19120474
10.

Interferons: signaling, antiviral and viral evasion.

Bonjardim CA, Ferreira PC, Kroon EG.

Immunol Lett. 2009 Jan 29;122(1):1-11. doi: 10.1016/j.imlet.2008.11.002. Epub 2008 Dec 6. Review.

PMID:
19059436
11.

Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.

Sinkovics JG, Horvath JC.

Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Review.

PMID:
19104757
12.

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

Ahtiainen L, Mirantes C, Jahkola T, Escutenaire S, Diaconu I, Osterlund P, Kanerva A, Cerullo V, Hemminki A.

PLoS One. 2010 Nov 5;5(11):e13859. doi: 10.1371/journal.pone.0013859.

14.

IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T.

Nature. 2005 Apr 7;434(7034):772-7. Epub 2005 Mar 30.

15.

Signaling pathways activated by microorganisms.

Takeuchi O, Akira S.

Curr Opin Cell Biol. 2007 Apr;19(2):185-91. Epub 2007 Feb 15. Review.

PMID:
17303405
16.

A central role for RNA in the induction and biological activities of type 1 interferons.

Li XL, Ezelle HJ, Hsi TY, Hassel BA.

Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):58-78. doi: 10.1002/wrna.32. Epub 2010 Aug 24. Review.

PMID:
21956969
17.

Cell-type-specific innate immune response to oncolytic Newcastle disease virus.

Biswas M, Kumar SR, Allen A, Yong W, Nimmanapalli R, Samal SK, Elankumaran S.

Viral Immunol. 2012 Aug;25(4):268-76. doi: 10.1089/vim.2012.0020. Epub 2012 Jul 18.

18.

Innate immune response to viral infection.

Koyama S, Ishii KJ, Coban C, Akira S.

Cytokine. 2008 Sep;43(3):336-41. doi: 10.1016/j.cyto.2008.07.009. Epub 2008 Aug 9. Review.

PMID:
18694646
19.

Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7.

Balachandran S, Venkataraman T, Fisher PB, Barber GN.

J Immunol. 2007 Feb 15;178(4):2429-39.

20.

Bovine herpesvirus type 1 as a novel oncolytic virus.

Rodrigues R, Cuddington B, Mossman K.

Cancer Gene Ther. 2010 May;17(5):344-55. doi: 10.1038/cgt.2009.77. Epub 2009 Nov 6.

PMID:
19893594

Supplemental Content

Support Center